MIRA has 36-month beta value of 2.64. Analysts have mixed views on the stock, with 2 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for MIRA is 11.44M, and currently, short sellers hold a 11.03% ratio of that float. The average trading volume of MIRA on November 21, 2024 was 2.00M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
MIRA) stock’s latest price update
Mira Pharmaceuticals Inc (NASDAQ: MIRA)’s stock price has decreased by -9.64 compared to its previous closing price of 1.40. However, the company has seen a -18.91% decrease in its stock price over the last five trading sessions. accesswire.com reported 2024-11-20 that Backed by a Strong Balance Sheet, MIRA Accelerates Toward Becoming a Clinical-Stage Company and Advancing Breakthroughs in Pain and Depression Treatment MIAMI, FL / ACCESSWIRE / November 20, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company, is pleased to announce the selection of The Centre for Human Drug Research (CHDR) in Leiden, The Netherlands, as the site for its Phase I/IIa clinical trial of Ketamir-2, a novel oral ketamine analog. Recruitment for the trial is set to begin in Q1 2025, with initial safety and efficacy results from the Phase I study in healthy subjects expected in the second half of 2025.
MIRA’s Market Performance
MIRA’s stock has fallen by -18.91% in the past week, with a monthly rise of 20.48% and a quarterly drop of -32.35%. The volatility ratio for the week is 11.80% while the volatility levels for the last 30 days are 17.56% for Mira Pharmaceuticals Inc The simple moving average for the last 20 days is -22.57% for MIRA stock, with a simple moving average of 2.92% for the last 200 days.
MIRA Trading at -5.56% from the 50-Day Moving Average
After a stumble in the market that brought MIRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -80.23% of loss for the given period.
Volatility was left at 17.56%, however, over the last 30 days, the volatility rate increased by 11.80%, as shares surge +18.22% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -10.28% lower at present.
During the last 5 trading sessions, MIRA fell by -18.91%, which changed the moving average for the period of 200-days by +12.95% in comparison to the 20-day moving average, which settled at $1.6337. In addition, Mira Pharmaceuticals Inc saw 20.48% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MIRA starting from Erez Aminov, who proposed sale 100,000 shares at the price of $1.41 back on Nov 19 ’24. After this action, Erez Aminov now owns shares of Mira Pharmaceuticals Inc, valued at $141,000 using the latest closing price.
Brian McNulty, the affiliate of Mira Pharmaceuticals Inc, proposed sale 10,000 shares at $1.80 during a trade that took place back on Sep 04 ’24, which means that Brian McNulty is holding shares at $18,000 based on the most recent closing price.
Stock Fundamentals for MIRA
The total capital return value is set at -3.0. Equity return is now at value -192.32, with -169.22 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 6.11.
Conclusion
To put it simply, Mira Pharmaceuticals Inc (MIRA) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
